em | Notes |
|---|
Quorum evaluation (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business) | Currently we have 19 named members, so 2/3 = 12 (excluding chair and government members). |
Open Meeting | |
Follow up Items | |
Presentations etc | Children’s Health Laboratory Medicine Conference Feb 16 - Andrea and Riki will present SHIELD overview with the specific viewpoint around impact of SHIELD work on laboratorians - bring slides for review on SC call Feb 6th API submitted SHIELD abstract for Hung Luu to present, if accepted
|
CAP Today Article Update | Next steps: |
Review Working Groups progress | Setting milestones for deliverables should be NEXT for WGs: they will be captured here: SHIELD WG Deliverables and Milestone Grid |
2024/25 Conferences we might want to submit abstracts to | Executive War College Apr 30 – May 1, 2024 in New Orleans, LO Steve will be attending - need any help? SHIELD flyers? ADLM (submission deadlines for 2024 presentations passed, but consider 2025)
|
LOINC Chairs Meeting (1/11/2024) | Discussed Patient Generated Health Data (PGHD) as cross-cutting topic: This followed a Pre/Post coordination discussion across all committees on the agenda; nursing and radiology have much different needs than lab when it comes to pre/post coordination BUT a solution needs to be applicable for all areas of LOINC PGHD example: Medicare patient who’s kidney function monitored for decadse, sent home urinalysis kit. http://Healthy.IO Insurer followed up several times when they hadn’t complied. Different Information Flow is observed Seems to be recorded through Insurer database for patient; not necessarily including the medical record from dr office notes or from laboratory reporting to inpatient/outpatient records LOINC used in HEDIS ; more of an administrative use case for physician care over their patient populations. Lab LOINC’s post around National Kidney Foundation question about microalbumin/creatinine home kit being used to satisfy a quality/ HEDIS measure. (Resolution: qualitative results reported, incorrect LOINCused/didn’t meet quality reporting criteria.) Awaiting 2024 task force discoveries cross-cutting within LOINC committees (NEXT STEPS below).
FDA is approving these devices, but appears IVD vendors are not requesting LOINCs for these new test methods. Many IVD vendors not yet providing LOINC maps in LIVD format. FDA, ONC / USCDI, standards development future impacts? HL7 FHIR PGHD Implementation Guide is for consumer performed testing reported to public health https://projectlifedashboard.hl7.org/specifications/hl7-fhir-us-home-lab-report-v0-1-0/
|
Sequoia Lab Tiger Team call 11Jan2024 | https://sequoiaproject.org/interoperability-matters/data-usability-workgroup/ |
Roadmap section updates in response to ONC comments on the SHIELD roadmap | The roadmap mission section describes a broad vision of lab interoperability. However, the roadmap proposed solution is limited to the FDA use cases around In-vitro diagnostics (IVD) data, specifically populating the IVD data hub. ONC suggests clearly describing the roadmap scope so the proposed solutions can be discussed within that context.
Looking for volunteer to tackle this re-write: Reordering the Considerations and moving the IVD Data hub last and renaming the section to “Making Well Standardized Data Available for Secondary Use” - we could then list as a first use case the IVD data hub, but we could expand this section with other uses we described under the business drivers and expand more on what each individual stakeholder can do to improve interoperability in the section on moving data through the systems The roadmap identifies training and education needs around using LOINC as a barrier to interoperability. ONC suggests clarifying how the roadmap addresses this barrier. ONC recognizes that terminologies require training and education, and replacing LOINC with another standard will not address the barrier.
Update from Standards and Vocab WG about re-write of this section There are several solutions proposed, including repositories and tools, which need to be further evaluated before ONC could fully support the roadmap. ONC suggests the roadmap be updated to include details around feasibility, scalability and how the proposed changes can be integrated into the current laboratory ecosystem (e.g., regulation and industry).
Renaming of LIDR update from LIDR WG: Looking for volunteer to tackle this re-write: For each of the Consideration sections we could certainly add a section on feasibility / requirements (e.g. continued funding for LIDR, better describing the intended use of ANY data element added, overall goal of LIDR, clearly delineate what is commonly used and is minimum, provide best practice and alternatives (non-preferred) - example would be metadata around the value sets in VSAC (curation / usage etc) to be able to ascertain quality) and highlight that other mechanisms are needed to achieve for adoption |
Next calls | All SHIELD: General Updates: January 23, 2024 Special Topic: February 13, 2024 - LOINC Naming Conventions SC: February 6, 2024 |
Adjourned | |